| Date | Title | Description |
| 02.05.2024 | Brazilian data and AI consultancy Indicium raises $40M for US expansion
Your vote of support is important to us and it helps us keep the content FREE.
One click below supports our mission to provide f... | Brazilian data and artificial intelligence consultancy startup Indicium today announced that it had raised $40 million in new funding to expand its operations in the U.S.
Founded in 2017, Indicium helps enterprises become “data-driven” usin... |
| 27.04.2024 | India becoming attractive for clinical trials, says pharma industry leaders | - |
| 24.04.2024 | Pharma exports rise around 10% to $27.9 billion, US biggest importer | - |
| 24.04.2024 | Govt expands committee for drugs, medical devices pricing reforms | - |
| 23.04.2024 | The future of healthcare on display: Day 1 of Medlab West Africa wraps up | The first day of the highly anticipated Medlab West Africa Exhibition and Conference has drawn to a close, leaving attendees and exhibitors alike buzzing with excitement. The venue was a hive of activity, showcasing the latest advancements ... |
| 21.04.2024 | HHCN engages with states to boost preventive care for treating Haemophilia | - |
| 17.04.2024 | World Hemophilia Day 2024"Equitable access for all: recognizing all bleeding disorders" | MONTREAL, April 17, 2024 /PRNewswire/ -- On April 17, 2024, the global bleeding disorders community will come together to celebrate World Hemophilia Day. The theme of the event this year is "Equitable access for all: recognizing all bl... |
| 16.04.2024 | Innovent Announces the Appointment of Dr. Nageatte Ibrahim as the Oncology Chief Medical Officer (CMO) | SAN FRANCISCO and SUZHOU, China, April 16, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for... |
| 15.04.2024 | Швейцарии предложено разобраться в себе | - |
| 15.04.2024 | Women of Influence: Health Care 2024 – Ileana Hernandez | - |
| 10.04.2024 | Roche Diagnostics India's Heart Failure Test for Diabetics Now Available on its Point-of-care Device | Mumbai, Maharashtra, India
Roche Diagnostics India announces the launch of its point-of-care NT-proBNP test for screening diabetes patients who are at risk of cardiovascular diseases (CVD) such as heart failure (HF). This breakthrough innov... |
| 08.04.2024 | Innovent to Present Preclinical Data of Multiple Novel Molecules at the 2024 AACR Annual Meeting | ROCKVILLE, Md. and SUZHOU, China, April 8, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for... |
| 02.04.2024 | Innovent and HUTCHMED Jointly Announce NDA Acceptance in China for Sintilimab Combination with Fruquintinib for the Treatment of Advanced Endometrial Cancer with Priority Review Status | ROCKVILLE, Md. and SUZHOU, China, April 2, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for... |
| 29.03.2024 | Indiana 250: Sue Ellspermann | - |
| 21.03.2024 | Advances in Digitalization Presented at the 10th Annual Genedata Biopharma Partner Symposium | Digitalizing Biopharma R&D: The Genedata Biopharma Platform is the #1 enterprise software system for achieving operational excellence in biopharma R&D.
Leading scientific, IT, and business innovators in the biopharma industry showca... |
| 21.03.2024 | PocketHealth secures $33M for patient-facing medical records platform | Photo: Luis Alvarez/Getty Images
PocketHealth, a platform that enables patients to access their medical imaging, announced it secured $33 million in an all-equity Series B funding round led by Round13 Capital.
Deloitte Ventures participated... |
| 20.03.2024 | Innovent Announces 2023 Annual Results and Business Updates | A transformative year of strong performance and material innovation progress
ROCKVILLE, M.D. and SUZHOU, China, March 20, 2024 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that d... |
| 20.03.2024 | Women are Reshaping the AI Talent Landscape New Research Shows Exponential Global Growth | Zeki Research finds Women prioritize excellence in research, science, and engineering throughout their careers and express greater interest in making AI safe for society through their professional work
LONDON, March 20, 2024 /PRNewswire/ --... |
| 19.03.2024 | IU lands $20M donation to establish lung cancer research center | - |
| 19.03.2024 | Innovent Announces Primary Endpoint Met in the Second Phase 2 Clinical Trial of IBI302 (anti-VEGF/complement) in Treating Neovascular Age-related Macular Degeneration (nAMD) | ROCKVILLIE, Md. and SUZHOU, China, March 19, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines f... |
| 18.03.2024 | Everest Medicines Strengthens Management Team with Appointments of Chief Medical Officer and Chief Product Officer | SHANGHAI, March 18, 2024 /PRNewswire/ -- Everest Medicines (HKEX: 1952.HK, "Everest," or the "Company"), a biopharmaceutical company focused on the discovery, development, manufacturing and commercialization of innovativ... |
| 13.03.2024 | Global Oncologists Market Report 2024: Precision Medicine and Therapeutic Advancements Drive Expansion to $22.72 Billion by 2028 | - |
| 13.03.2024 | Top 7 Markets In Pharmaceuticals Industry – By The Business Research Company | - |
| 13.03.2024 | Cancer Immunotherapy Market Research 2024: The Race for the Cures - Forecasts for Immuno-Oncology Therapeutics by Therapy, Cancer and Customer including Executive and Consultant Guides | - |
| 13.03.2024 | После вмешательства генпрокурора РФ 68 южноуральцев обеспечены лекарствами | - |
| 13.03.2024 | Europe Pharmaceutical Suspension Market Report By Type, By Distribution Channel, By End User, By Indication (Cancer, Neurological, Infectious Diseases, Gastrointestinal, and Others) Forecast to 2030 | - |
| 13.03.2024 | Point Of Care Diagnostics Market By Product (Infectious Diseases, Glucose Testing, Cardiac Markers), By End-use (Clinics, Home, Hospitals), By Region, And Segment Forecasts, 2024 - 2030 | - |
| 12.03.2024 | Biologics Market Size Expected to Reach USD 845.78 Billion by 2033 | - |
| 12.03.2024 | Roche Annual General Meeting 2024 | - |
| 12.03.2024 | Innovent to Present Preclinical Data of Multiple Novel Molecules at the 2024 AACR Annual Meeting | ROCKVILLE, Md. and SUZHOU, China, March 12, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines fo... |
| 12.03.2024 | Global Women’s Health Devices Market Forecast 2024-2033 – Market Size, Drivers, Trends, And Competitors | Women’s Health Devices Global Market Report 2024 – Market Size, Trends, And Forecast 2024-2033
The Business Research Company’s Women’s Health Devices Global Market Report 2024 – Market Size, Trends, And Forecast 2024-2033
It will grow to $6... |
| 12.03.2024 | Cardiac Marker Analyzer Market to Hit US$ 1.38 Billion by 2034: Fact.MR Report | - |
| 12.03.2024 | Molecular Diagnostics in Infectious Disease Sector Projects Significant Growth and Technological Advances from 2024-2028 | - |
| 12.03.2024 | Global Retinoblastoma Treatment Market Set to Reach $4.20 Billion by 2034 with Steady Growth in Targeted Therapies and Gene Treatment | - |
| 12.03.2024 | STD Diagnostics Market to Reach USD 16.06 Billion by 2030, Driven by Rising Incidence & Improved Screening Technologies | STD diagnostics Market
STD Diagnostics Market Analysis, Size, Share, Industry Trends and Growth Outlook AUSTIN, TEXAS, UNITED STATES, March 12, 2024 /EINPresswire.com/ -- The global sexually transmitted disease (STD) diagnostics market is p... |
| 11.03.2024 | In Vitro Diagnostics (IVD) Market is Expected to Reach $130.1 Billion by 2030 - Exclusive Report by Meticulous Research® | According to Meticulous Research®, the global in vitro diagnostics market is expected to register a CAGR of 4.6% from 2023 to reach $130.1 billion by 2030. REDDING, UNITED STATES, March 11, 2024 /EINPresswire.com/ -- According to a new mark... |
| 11.03.2024 | Global $111+ Billion Duchenne Muscular Dystrophy (DMD) Drugs Market Analysis 2024-2034 - Rapid Growth in Exon-Skipping Therapies Reflects Precision Medical Interventions Fueled by R&D | - |
| 11.03.2024 | Contract Research And Manufacturing Services (CRAMS) Market Size, Share And Growth Analysis For 2024-2033 | Contract Research And Manufacturing Services (CRAMS) Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033
The Business Research Company's Contract Research And Manufacturing Services (CRAMS) Global Market Report 20... |
| 11.03.2024 | Asia-Pacific Next-Generation Breast Cancer Diagnostic and Screening Market 2023-2032: Liquid Biopsy for Breast Cancer Diagnosis and Complete Automation of Next-Generation Techniques are the Key Trends | - |
| 11.03.2024 | Infusion Pump Software Market to Cross USD 1660 Million by 2030 | Infusion Pump Software Market
Infusion Pump Software Market Analysis, Industry Overview and Growth Outlook AUSTIN, TEXAS, UNITED STATES, March 11, 2024 /EINPresswire.com/ -- The Global Infusion Pump Software Market is expected to reach 1660... |
| 11.03.2024 | New ASCCP cervical cancer management guidelines now include dual-stain triage testing with Roche's CINtec® PLUS Cytology to enable earlier diagnosis | Updated American Society of Colposcopy and Cervical Pathology (ASCCP) guidelines recognize the importance of dual-stain biomarkers in managing early diagnosis of HPV- positive cervical precancer and cancer.
Earlier detection may significant... |
| 11.03.2024 | Impact Guru Healthcare Excellence Award Celebrates Outstanding Achievements Across Diverse Sectors | Mumbai, Maharashtra, India
Impact Guru, India’s leading medical crowdfunding platform has announced the winners of the inaugural Impact Guru Healthcare Excellence Award. The award celebrates organizations and individuals who have demonstrat... |
| 08.03.2024 | Collaboration Deals in Pharmaceuticals Through 2019-2024 Featuring 1900+ Market Players | - |
| 08.03.2024 | Asset Purchase Deals in Pharmaceuticals and Biotechnology 2016-2024: Trends, Deal Structure, Leading Deals by Value, Most Active Dealmakers, and More | - |
| 08.03.2024 | Gynecology Drugs Market Size, Share And Growth Analysis For 2024-2033 | Gynecology Drugs Global Market Report 2024 – Market Size, Trends, And Global Forecast 2023-2032
The Business Research Company's Gynecology Drugs Global Market Report 2024 – Market Size, Trends, And Global Forecast 2023-2032
The Business Res... |
| 08.03.2024 | In Vitro Diagnostics Market Size Worth USD 128.33 Bn by 2033 | - |
| 08.03.2024 | Hepatitis Testing/Diagnosis Market is growing at a CAGR of 5% from 2024 to 2030 by Exactitude Consultancy | Hepatitis Testing/Diagnosis Market
The Exactitude Consultancy Hepatitis Testing/Diagnosis Market Report – Size, Trends, and Forecast 2024-2030
The demand for hepatitis testing/diagnosis is increasing due to rising awareness, prevalence of h... |
| 08.03.2024 | Psychedelic Drugs Market Size, Share And Growth Analysis For 2024-2033 | Psychedelic Drugs Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033
The Business Research Company has updated all its market reports with the latest information for the year 2024, projecting trends and forecasts... |
| 08.03.2024 | Influenza Diagnostics Market Share Estimated to Reach USD 1.46 Billion By 2032, at 7.1% CAGR Growth: Polaris Market Research | - |
| 08.03.2024 | Asia-Pacific's Next-Generation IVD Market Worth $42+ Billion by 2033: Key Insights by Type, End-user and Country | - |
| 08.03.2024 | Hepatitis Drugs Market Size, Share And Growth Analysis For 2024-2033 | Hepatitis Drugs Market Report 2024 – Market Size, Trends, And Forecast 2024-2033
The Business Research Company has updated its global market reports with latest data for 2024 and projections up to 2033
The hepatitis drugs market size is exp... |
| 07.03.2024 | Global Pharmaceuticals and Biotechnology Distribution Partnering Agreements Trends Report 2024: Insights into Financial and Legal Aspects of Distribution Agreements Signed Since 2016 | - |
| 07.03.2024 | Precision Medicine in Oncology Collaboration and Licensing Deals 2016-2023 | - |
| 07.03.2024 | Global Hemophilia Treatment Regimen and Therapy Research Report 2024: Market to Surpass $17.75 Billion by 2028, Driven by the Development of Novel Hemophilia Treatments | - |
| 07.03.2024 | United States Medical Diagnostics Analysis Report 2024-2028: Growing Burden of Chronic Diseases, Escalating Use of EHR Systems and Rising Healthcare Expenditure Driving Growth | - |
| 07.03.2024 | Europe Medical Diagnostics Analysis Report 2024: A $109.91 Billion Market by 2028 with Focus on Immunoassays, Clinical Chemistry, Haematology & Coagulation | - |
| 06.03.2024 | Kidney Function Tests Market to hit USD 1.5 Bn by 2032, says Global Market Insights Inc. | - |
| 06.03.2024 | Capecitabine Global Market Report 2024 | - |
| 06.03.2024 | Asia Pacific Point Of Care Diagnostics Market Forecasted to Surge, Reaching USD 15.61 Billion by 2030 with a CAGR of 8.1% | - |
| 06.03.2024 | Myeloproliferative Disorders Drugs Market Report 2024-2033: Increased Investments in R&D Driving the Industry | - |
| 05.03.2024 | Roche and Alnylam report positive topline results from the Phase II KARDIA-2 study in people with hypertension, demonstrating clinically significant blood pressure reductions with zilebesiran when add... | - |
| 05.03.2024 | Global Lung Cancer Diagnostics Market Worth $30.84 Billion by 2030, Influenced by Advanced Imaging and Biomarker Testing | - |
| 05.03.2024 | Point-of-Care (POC) Diagnostics Market to Reach $82.28 Billion by 2030, Driven by the Burgeoning Demand for Early Detection of Diseases | - |
| 05.03.2024 | Interleukin-2 (IL-2) Inhibitor Drug Pipeline Research Report 2024 | - |
| 05.03.2024 | Biotechnology Industry Insights: Comprehensive Report on Collaboration Deals from 2019-2024 Now Available | - |
| 05.03.2024 | Diagnostic Industry Revelations: Comprehensive Analysis of Global Distribution Deals from 2016 to 2024 Unveiled | - |
| 05.03.2024 | Biotechnology Licensing Deals Analysis Reveals Key Trends and Major Agreements from 2019-2024 | - |
| 05.03.2024 | Latin America Point of Care Diagnostics Market Growth Forecast Through 2030 | - |
| 05.03.2024 | Pharmaceutical and Biotechnology Royalty Rate Trends Unveiled in Comprehensive New Report | - |
| 05.03.2024 | Global Autoimmune Diseases Diagnostics Market to Reach $8.64 Billion by 2030 - Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis | - |
| 04.03.2024 | Growth Trajectory Of Merkel Cell Carcinoma Treatment Market: Market Size To Reach $4.2 Billion By 2028 As Per The Business Research Company's Merkel Cell Carcinoma Treatment Global Market Report 2024 | Exclusive Offer By The Business Research Company - Get 33% Discount On Opportunities And Strategies Reports
LONDON, March 04, 2024 (GLOBE NEWSWIRE) -- As per The Business Research Company’s Merkel Cell Carcinoma Treatment Global Market Repo... |
| 04.03.2024 | Understanding The Growth Potential Of Progressive Multifocal Leukoencephalopathy Treatment Market: Expected Market Size And Growth Factors As Per The Business Research Company's Progressive Multifocal... | Exclusive Offer By The Business Research Company - Get 33% Discount On Opportunities And Strategies Reports
LONDON, March 04, 2024 (GLOBE NEWSWIRE) -- The Business Research Company’s Progressive Multifocal Leukoencephalopathy Treatment Glob... |
| 04.03.2024 | Rising Demand and Advancements in Europe IVD Market 2024: Assisted Reproductive Technology for Fertility Solution | Europe In Vitro Diagnostics Market 2024
Demand forin vitro diagnosticsis on therise, owing to surge in prevalence of various chronic diseases which require use of IVD tests for diagnosis
PORTLAND, OREGON, UNITED STATES, March 4, 2024 /EINPr... |
| 04.03.2024 | Pharmaceutical Manufacturing Market Projected to Grow at 7.8% CAGR, Reaching $863.6 Bn by 2030 | Vantage Market Research | Vantage Market Research
Pharmaceutical Manufacturing Market Size, Share, Industry Trends, Growth, and Opportunities Analysis by 2030 WASHINGTON, D.C, DISTRICT OF COLUMBIA, UNITED STATES, March 4, 2024 /EINPresswire.com/ -- The Global Pharma... |
| 27.02.2024 | Freenome scores $254M to advance its cancer-detection blood tests | The San Francisco company readies to reveal its first clinical study results in the near term
When it comes to cancer, spotting it early can make a big difference on treatment options and survival. Commonly a progressive disease, certain un... |
| 20.02.2024 | Freenome's $254M Boost for Early Cancer Detection | Freenome, a biotech company in San Francisco, just secured a massive $254M in funding to advance their blood-based cancer detection tests. The investment, led by Roche and backed by a slew of other big names, will propel Freenome's mission ... |
| 15.02.2024 | Freenome Raises $254M to Accelerate Early Cancer Detection Platform | What You Should Know:
– Freenome, a leader in blood-based early cancer detection, has raised $254M in a new funding round, fueled by its innovative multiomics platform and promising pipeline of tests. The funding was led by Roche with parti... |
| 01.02.2024 | Novavax is on thin ice, and the latest update isn’t exactly encouraging | Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hello, everyone. Damian here with the latest twist in biotech’s recovery, a close look at Bluebird Bio, and the unce... |
| 24.01.2024 | Dutch-based Verdify bags €2.4M to make healthy and sustainable eating easy; here’s how | Read this article in:
Limburg-based Verdify, a foodtech company, announced that it has secured €2.4M in a fresh round of funding from existing and new investors, including Goeie Grutten Impact Fund, Oost NL, Koppert Cress, and De Smaakmaker... |
| 19.12.2023 | Roche navify digital solutions get excellent ratings from healthcare professionals in KLAS Research reports | Healthcare professionals greatly value navify Tumor Board for improving tumour board meeting experiences, offering a holistic view of data, facilitating multidisciplinary team collaboration and optimising care decisions
navify POC Operation... |
| 28.10.2023 | Roche Teams Up with Ibex and AWS to Advance AI-Powered Digital Pathology for Enhanced Cancer Diagnosis | Roche’s navify Digital Pathology software platform now offers Ibex’s Artificial Intelligence (AI) algorithms to support clinicians in the diagnosis of breast and prostate cancer.
Roche announced collaborations with Ibex Medical Analytics an... |
| 02.10.2023 | Generative AI start-up Silver Brain AI enters the market with Roche | |
| 05.09.2023 | Economist Impact report, Advancing the frontier of health and technology integration: The 2023 Digital Health Barometer highlights opportunities in digitalisation of healthcare | The report shows digital health technologies demonstrate value, yet integrating them into care systems remains challenging. Involving healthcare professionals and patients in technology design and development is also critical for patient-ce... |
| 27.06.2023 | Nvidia backs Flywheel in $54M round to accelerate medical AI development | Join top executives in San Francisco on July 11-12, to hear how leaders are integrating and optimizing AI investments for success. Learn More
Hours after teaming up with data cloud major Snowflake, Nvidia has backed a vendor working to over... |
| 11.05.2023 | Biotech startup DiogenX secures €27.5M to develop therapeutic solutions for Type 1 diabetes | Marseille-based DiogenX, a preclinical-stage biotech company specialising in the development of pancreatic beta-cell modulators for the treatment of diabetes, announced on Wednesday, May 10, that it has raised €27.5M in a Series A round of ... |
| 05.04.2023 | Roche Diagnostics India Unveils #BeYourOwnShero Campaign to Educate Women About Cervical Cancer Prevention | Mumbai, Maharashtra, India
Cervical Cancer is India’s second most common cancer, affecting more than 1.23 lakh women each year. Around 77,000 Indian women die of the disease. Despite being the only preventable cancers, awareness about effec... |
| 06.01.2023 | The FDA just approved a new Alzheimer's drug that's set to be a blockbuster | Getty Images
The FDA just approved a new treatment for Alzheimer's disease from Eisai and Biogen. In a large study, the drug slowed the rate of cognitive decline in patients by 27%. Alzheimer's disease affects roughly 6.5 million Americans ... |
| 08.12.2022 | Roche Diagnostics Sets New Milestone in the Middle East with ISO27001 Information Security Certification | “Roche” Diagnostics Middle East FZCO has set a new milestone as the first in-vitro diagnostics company in the Middle East to secure the prestigious ISO27001 Information Security certification in recognition of its exceptional commitment to ... |
| 18.11.2022 | Why Top Brands Should Rethink Adaptive Fashion And Take It Seriously | On the runway at the Double Take adaptive fashion show on September 8 2022IMAXTree for Genentech |
| 15.11.2022 | Zest wants to make buying and sending gifts online ‘delightful’ | While e-commerce was on the rise before the pandemic, the massive shift to digital supercharged the online shopping industry — bringing entirely new categories of products (and shoppers) to the web. According to Adobe, Americans have spent ... |
| 14.11.2022 | A top Wall Street analyst names 6 major events that could send biotech stocks soaring between now and the end of 2022 | Medical samples in vacutainer tubes held by a laboratory technician. Matthew Horwood/Getty Images This story is available exclusively to Insider subscribers. Become an Insider and start reading now.
Redeem now
Investors need to pay attentio... |
| 04.11.2022 | Roche introduces the navify brand for its digital health solutions at HLTH 2022 | Roche unifies its digital health portfolio under the navify brand, providing a range of next generation software solutions. The navify portfolio uses digital solutions, analytics and data science to provide insights that address today's rea... |
| 04.11.2022 | Roche introduces the navify brand for its digital health solutions at HLTH 2022 | Roche unifies its digital health portfolio under the navify brand, providing a range of next generation software solutions.
The navify portfolio uses digital solutions, analytics and data science to provide insights that address today's rea... |
| 24.10.2022 | Roche receives FDA clearance for COVID-19 PCR test for use on cobas 6800/8800 Systems | The cobas SARS-CoV-2 Qualitative test is one of the first COVID-19 PCR tests performed on an automated, high throughput platform to receive FDA 510(k) clearance.
This FDA clearance will ensure that the healthcare community has access to tim... |
| 19.10.2022 | Roche to present new OCREVUS (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ECTRIMS 2022 | OCREVUS data will show significant benefit on slowing disease activity and progression in patients with treatment-naive early-stage relapsing-remitting multiple sclerosis (RRMS)Largest pregnancy safety data across anti-CD20 medicines for OC... |
| 12.10.2022 | Positive new data for Roche’s Evrysdi in largest trial ever undertaken in patients with previously-treated spinal muscular atrophy (SMA) | New two-year Evrysdi data show improvement or maintenance of motor function in people with SMA, a progressive neuromuscular disease that can be fatal The JEWELFISH study enrolled the broadest and most diverse patient population ever studied... |
| 12.10.2022 | Roche to introduce its next-generation portfolio of SARS-CoV-2 rapid antigen tests (“2.0”) under CE Mark for self-test and professional use | Broad and trusted portfolio of COVID-19 rapid tests feature innovative updates and enhanced performance, building on insights gained throughout the pandemicAll tests now work seamlessly with navify® Pass, Roche’s digital solution that allow... |
| 11.10.2022 | Roche launches PRAME (EPR20330) Antibody to identify PRAME protein expression in patients that may have melanoma | The PRAME (EPR20330) Antibody evaluates PRAME protein expression from patients with suspected melanoma. Understanding if the PRAME protein is expressed helps enable more informed clinical decisions and may improve patient outcomes.The PRAME... |
| 05.10.2022 | Roche to present new data from its expanding neuromuscular disease portfolio at World Muscle Society 2022 | New positive data from Evrysdi, a treatment for spinal muscular atrophy (SMA), a progressive neuromuscular disease that can be fatalData from the gene therapy programme for Duchenne muscular dystrophy (DMD), a progressive disease that leads... |
| 04.10.2022 | Roche receives FDA approval for first companion diagnostic to identify patients with HER2 low metastatic breast cancer eligible for ENHERTU | Approximately half of all patients with metastatic breast cancer (mBC) express low levels of HER2. These patients with HER2 low status may now be eligible for a targeted treatment, which could significantly improve their outcomes.1,2The PAT... |
